Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
106.89 USD
-0.65%
Market Closed
Updated:
Apr 25, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
4.7
Current
4.8
Median
2.4
Industry
Lower
than median
Higher
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=4.7
Enterprise Value
/
191.4B
Revenue
40.3B
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| US |
|
Abbott Laboratories
NYSE:ABT
|
185B USD | 4.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
131.8B USD | 17.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
128.2B USD | 6.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
107.4B USD | 8.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.9B USD | 3.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.6B USD | 4.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.9B EUR | 3.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
53.1B USD | 8.7 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
52.6B USD | 14.5 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
345.7B CNY | 9.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
41B USD | 11.3 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
4.5
2-Years Forward
EV/S
4.2
3-Years Forward
EV/S
3.9
You don't have any saved screeners yet
